By now you should have been notified about our organizations next important step in the transition of joining AAIPharma Services Corp., a leading provider of drug product, development services and analytical testing, with Cambridge Major Laboratories, Inc., a world-class API drug developer and manufacturer. Effective March 16, 2016, our company will officially operate under the name Alcami [al-kuh-mee].
The previous name of our business units have been changed with state and local governments, in the D&B database, and with the FDA. All of our sites within our organization are doing business as (dba) Alcami Corporation. Following is a table that outlines how each site name / address / FEI / DUNS is identified with the FDA.